NCT00000595View on ClinicalTrials.gov

Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 1978

Study Completion Date

September 30, 1994

Conditions
Anemia (Iron-Loading)Beta-ThalassemiaHematologic DiseasesHemoglobinopathiesThalassemiaIron OverloadHemochromatosis
Interventions
DRUG

deferoxamine

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00000595 - Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis | Biotech Hunter | Biotech Hunter